Empyrean Capital Partners’s Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 PCPC.WS Stock Holding History

Empyrean Capital Partners’s Portfolio PCPC.WS Stock Details PCPC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-216,855	Closed	-$161K	–	191
2022 Q1	$161K	Hold	216,855	–	–	﹤0.01%	172
2021 Q4	$353K	Hold	216,855	–	–	0.01%	161
2021 Q3	$339K	Hold	216,855	–	–	0.01%	169
2021 Q2	$466K	Hold	216,855	–	–	0.01%	173
2021 Q1	$406K	Buy	+216,855	New	+$623K	0.01%	150

Other funds holding PCPC.WS

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AMH

Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return

Empyrean Capital Partners's PCPC.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) in Q2 2022, closing a stake of 216,855 shares — an estimated $161K sold.

Empyrean Capital Partners first reported a position in PCPC.WS in Q1 2021 and held it in 5 quarters. The position peaked at $466K in Q2 2021. 29 funds tracked by Wall St. Rank hold PCPC.WS as of Q2 2022.

Empyrean Capital Partners reported no remaining Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position as of Q2 2022 after selling out during the quarter.
Empyrean Capital Partners sold 216,855 Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 shares in Q2 2022, an estimated $161K.
Empyrean Capital Partners first reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in Q1 2021 and held it in 5 quarters.
Empyrean Capital Partners's Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position peaked at $466K in Q2 2021.
29 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.